To study how intestinal intraepithelial lymphocytes (IEL) are aŠected by orally ingested antigen, the phenotypes and responses of the IEL in mice expressing a transgenic T cell receptor ab (TCR ab) speciˆc for ovalbumin (OVA) were analyzed after feeding OVA. In the OVA-fed mice, the abundance of ab-IEL as a proportion of the total IEL population increased and the frequency of CD4 ＋ cells increased within the TCR ab ＋ IEL population. CD4 ＋ IEL from OVA-fed transgenic mice proliferated in vitro more markedly in response to antigen stimulation than IEL from mice fed the control diet. These results indicate that antigen-speciˆc proliferation of CD4 ＋ IEL was ampliˆed as a result of oral administration of antigen.
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The intestinal epithelium is a region in contact with the outside world, and exposed to the intestinal bacterial micro‰ora and food antigens (Ags). Intestinal intraepithelial lymphocytes (IEL) represent a very large population of T lymphocytes buried in the epithelial layer of villi in the intestinal lumen. In mice, about half of these cells express the T cell receptor (TCR) ab (ab-IEL), while the other half express TCR-gd (gd-IEL). The majority of ab-IEL are CD8 ＋ , half of them expressing the CD8aa homodimer. 1, 2) In contrast, peripheral CD8 ＋ T cells which have developed in the thymus generally express the CD8ab heterodimer. In the thymus, CD4 ＋ CD8 ＋ cells are immature, while there are mature CD4 ＋ CD8 ＋ cells among the IEL. These observations demonstrate that the IEL are composed of populations distinct from peripheral T cells in the systemic immune system, although the molecular contexts of their recognition of Ags and their exact function are unknown. The ab-IEL population also contains a signiˆcant number of CD4 ＋ T cells. Although some studies have shown that CD4 ＋ IEL can respond to intestinal Ags, 3, 4) the antigenic recognition and eŠector functions of the CD4 ＋ IEL are still unclear.
Several studies have shown that IEL are aŠected by orally administered Ag. Stimulation was indirectly demonstrated in the case of celiac disease. The percentage of proliferating IEL increased in untreated patients. 5) Another experimental study indicated that mice fed OVA and administered cyclophosphamide i.p. showed gut symptoms similar to those of foodsensitive enteropathy and an increase in the abundance of IEL. 6) Priming of IEL by orally administered Ag was also demonstrated by results indicating that CD4 ＋ IEL in mice orally primed with sheep red blood cells were capable of providing a helper function for the Ag-speciˆc B cell response. 3) Based on these data, we assumed that these eŠects of ingested Ag on IEL were due to some speciˆc response of IEL to this Ag, not a non-immunological interaction with the Ag.
In this study we analyzed the IEL in OVA23-3 mice expressing a transgenic TCR ab speciˆc for OVA peptide 323-339 (OVA323-339) restricted to MHC class II I-A d . A majority of the ab-IEL in this transgenic mouse should express a single type of TCR speciˆc for this OVA peptide. It may be easier to observe an Ag-speciˆc response of the IEL in this transgenic mouse, which has more CD4 ＋ T cells capable of responding to OVA, compared with a wild-type (WT) mouse. We fed the transgenic mice a diet containing OVA and detected a change in the population and activation state of IEL speciˆc to the Ag fed, a change which has been rarely observed in WT mice. This study clearly shows that antigen-speciˆc proliferation of CD4 ＋ ab-IEL is upregulated in response to orally administered Ag.
Materials and Methods
Mice. This experiment was done in accordance with the Guidelines for Animal Experiments of the Faculty of Agriculture, The University of Tokyo, and the law (no. 105) and notiˆcation (no. 6) of the Japanese Government.
The establishment of the OVA23-3 transgenic mouse line used has been described. 7) These mice carry genes encoding TCR ab (Va3.1 W V b15) derived from an OVA-speciˆc CD4 ＋ T cell clone, 7-3-7. The animals were housed and bred in our animal facility at The University of Tokyo. We obtained WT and transgenic mice from the F1 generation of a cross between BALB W c and heterozygous transgenic mice. IEL were analyzed from transgenic mice of both sexes at 8-24 wk of age. Six to eight wk-old BALB W c mice were purchased from Clea Japan, Inc. (Tokyo, Japan).
Antibodies and reagents for FACS analysis. The monoclonal antibodies used in this study were the following: anti-pan TCR b chain (H57-597) conjugated to biotin was purchased from PharMingen (San Diego, CA). FITC-anti-CD4 (YTS191.1.2) and R-phycoerythrin (R-PE)-anti-CD8a (53.6.7) were obtained from Gibco, BRL (Gaithersburg, MD); anti-CD8 b (Y8.77)-FITC was from Seikagaku Corp. (Tokyo, Japan). Streptavidin-R-PE and FITC were products of Gibco, BRL. Streptavidin-PerCP was from Becton Dickinson Immunocytometry Systems (San Jose, CA). Anti-Va3.1 mAb (1H9) conjugated to biotin was prepared as previously described. 8) Isolation of IEL. IEL were prepared as previously described. 9) In brief, the inverted intestine was cut into four segments and these segments were transferred to a 50-ml conical tube containing 45 ml of 5z fetal bovine serum (FCS) (Cansera International, Rexdale, Canada) in Hanks' balanced salt solution. The tube was shaken at 150 rpm in the horizontal position in an orbital shaker for 45 min at 379 C. The cells were collected and passed through a glass-wool column to remove cell debris and adherent cells (the crude cell preparation). Subsequently, the cells were suspended in 30z Percoll (Pharmacia Biotech, Uppsala, Sweden) solution and centrifuged at 400×g for 20 min. Cells pelleted at the bottom of the tube were then put through Percoll discontinuous gradient centrifugation, and the IEL were recovered from the interface of 44z and 70z Percoll solutions (À95z were CD3-positive).
Preparation of Peyer's patch cells and splenocytes.
Peyer's patches were removed surgically from mouse intestine, and single-cell suspensions were prepared without enzymes by smashing the organ with the end of a syringe, and passing each cell suspension through a polyester mesh. Single-cell suspensions of splenocytes were prepared in a similar manner.
Oral administration of OVA. For a period of 3-10 days, the mice were allowed free access to a diet containing 20z egg-white protein (egg-white diet; ED) or a control diet containing 20z bovine casein (control casein diet; CCD), both of which had the same components except for egg white and casein (Table 1 ) (Funabashi Farms, Funabashi, Japan). The daily intake of OVA in the course of ED-feeding was approximately 250 mg.
Flow cytometry. Cells (2×10 5 W sample) were washed with Hanks' balanced salt solution containing 5z FCS and 0.2z NaN3 (the ‰ow cytometry buŠer) and centrifuged at 49 C, 400×g for 5 min. The cells were stained with each antibody on ice for 20 min. The samples were washed again, and ‰ow cytometry buŠer was added for analysis. Flow cytometry was done using a FACSort machine (Becton Dickinson Immunocytometry Systems). Aggregated cells were excluded by gating forward and side scatters for analysis. The frequencies of the subsets of IEL in the CCD-fed mice and ED-fed mice were compared using Student's two-tailed t test.
Magnetic cell sorting. IEL (1×10 7 -2×10 7 ) were Cells were stained with biotinylated anti-TCR b, or biotinylated anti-Va3.1 followed by incubation with streptavidin-R-PE. Data are the mean values for ten mice per group (seven mice for Va3.1 ＋ ) from three independent experiments. Statistical comparisons were done using Student's two-tailed t test. A diŠerence was signiˆcant at pº0.05 (indicated by *) when ab-IEL or Va3.1 ＋ IEL of ED-fed mice were compared to those of CCDfed mice. treated with anti-L3T4 (mouse CD4)-labeled MACS microbeads (Miltenyi Biotech, Bergish Gladbach, Germany). Thereafter, the magnetic microbeadlabeled IEL were separated into CD4 ＋ and CD4cell fractions on a column (type MS; Miltenyi Biotech) equilibrated with PBS (Nissui Pharmaceutical, Tokyo, Japan) containing 0.5z bovine serum albumin (Seikagaku Corp.) and 5 mM EDTA. The purity of each subset of IEL was conˆrmed by ‰ow cytometry. CD4 ＋ cell fractions of Peyer's patch cells and splenocytes were obtained in a similar manner.
Cell proliferation and cytokine assay. The whole splenocytes from BALB W c mice were irradiated with 3000 R and used as antigen-presenting cells (APC). IEL were plated in 96-well plates at 1 or 2×10 5 cells W well together with Ag and APC at 4×10 5 cells W well in a total volume of 200 ml. The medium for cell culture was RPMI 1640 (Nissui Pharmaceutical) containing 100 U W ml penicillin, 100 mg W ml streptomycin, 5× 10 -5 M 2-mercaptoethanol, and 10z FCS. After 24 or 48 h, 0.5 mCi of [ 3 H] thymidine was added to each well. The cells were harvested 20 h later and [ 3 H] thymidine incorporation was measured by scintillation counting. Cytokines in culture supernatants were measured using a two sites-sandwich enzymelinked immunosorbent assay (ELISA) as described previously. 11)
Results
Changes in the population of IEL in response to orally administered Ag OVA23-3 mice were fed ED (containing OVA) or CCD (lacking OVA). We compared the subsets of IEL in ED-fed mice with those in CCD-fed mice by analyzing surface molecule expression. In CCD-fed mice, 57±5z of puriˆed IEL was ab TCR ＋ and 44±6z IEL was positive for Va3.1, which is the achain of transgenic TCR speciˆc for OVA323-339. Therefore, it was evident that most of the ab-IEL in these transgenic mice expressed Va3.1 (Fig. 1) . Compared with CCD-fed mice, transgenic mice fed ED had an increased frequency (70±5z) of ab-IEL ( pº0.05) (Fig. 1) . The frequency of Va3.1 ＋ cells also increased as a result of ED feeding (60±5z, pº0.05) (Fig. 1) .
Tri-color staining showed that the TCRab ＋ cells were composed of CD4 -CD8 -, CD4 ＋ CD8 -, CD4 ＋ CD8 ＋ , and CD4 -CD8 ＋ (including CD8aa ＋ and CD8ab ＋ ) subsets. The frequency of CD4 ＋ CD8 -IEL in ED-fed mice was greater than that in CCD-fed mice ( pº0.01), while the frequency of CD8aa ＋ IEL was lower ( pº0.01) ( Figs. 2 and 3) . IEL phenotypes were also analyzed in transgenic mice that had been immunized i.p. with OVA. The analysis showed no diŠerence in IEL phenotypes between immunized and control mice (data not shown).
Changes in Ag-speciˆc reactivity of IEL in response to orally administered Ag IEL from ED-fed or CCD-fed mice (ED-IEL or CCD-IEL, respectively) were cultured with OVA in the presence of irradiated BALB W c splenocytes for an assay of cell proliferation. IEL from the ED-fed mice showed a stronger proliferative response to OVA than those from the CCD-fed mice (Fig. 4 ). IEL from mice fed a commercial diet (CE-2: Clea Japan) showed a proliferative response similar to that of IEL from CCD-fed mice (data not shown). However, ELISA of culture supernatants showed little diŠerence in interferon g production between CCD-IEL and ED-IEL (data not shown). Interleukin (IL-)4, IL-5, and IL-10 were not detected in the case of either ED-IEL or CCD-IEL (data not shown).
Proliferative response of CD4 ＋ and CD4 -IEL sorted by MACS CD4 ＋ and CD4cell fractions were obtained from IEL by MACS, and Ag-speciˆc proliferation of the IEL from ED-fed and CCD-fed mice was compared. The results (Fig. 5A ) showed that CD4 ＋ ED-IEL proliferated in response to OVA more strongly than CD4 ＋ CCD-IEL, while proliferation of CD4 -IEL was drastically weaker in the case of both CCD-and ED-IEL, compared with unfractionated IEL. On the other hand, little diŠerence was found in the proliferation of CD4 ＋ splenocytes and Peyer's patch cells from CCD-fed and ED-fed mice (Fig. 5B ). In order to investigate OVA-speciˆc ab-IEL particularly, cells were gated for positive staining with biotinylated anti-TCR b, followed by streptavidin-PerCP, as shown in A (IEL from CCD-fed mice) and D (IEL from ED-fed mice). ab-IEL from CCD-fed Tg mice (B and C) and ED-fed Tg mice (E and F) were each stained with FITC-coupled anti-CD4 and R-PE-coupled anti-CD8a (B and E), R-PEcoupled anti-CD8a and ‰uorescein isothiocyanate-coupled anti-CD8 b (C and F). Typical FACS proˆles are presented. 
Discussion
We analyzed IEL and their responsiveness in TCRtransgenic OVA23-3 mice fed the Ag for which this TCR is speciˆc. The purpose of this study was toˆnd which population of IEL is immunologically aŠected by orally administered Ag, i.e. OVA protein. We found that feeding ED increased the frequency of 
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Orally Administered Antigen AŠects CD4 ＋ IEL TCR ab ＋ cells and Va3.1 ＋ cells compared with IEL from CCD-fed mice (Fig. 1) . Furthermore, the frequency of CD4 ＋ cells within the TCR ab ＋ IEL population increased as a result of feeding ED (Figs. 2 and  3) . From the data obtained, it is demonstrable that the increase in frequency of TCR ab ＋ cells was due to an increase in size of the transgenic TCR ＋ population. These changes were not observed in the case of the IEL of i.p. immunized transgenic mice (data not shown). The results suggest that administration of Ag through the intestinal mucosa has unique eŠects on Ag-speciˆc CD4 ＋ ab IEL (discussed in detail below).
It has been often observed that IEL do not proliferate strongly in response to stimuli that are very eŠective for inducing proliferation of other systemic T cell populations in spleens or lymph nodes. 12, 13) The weak proliferating activity of the IEL was considered to re‰ect a state of low responsiveness due to having been exposed to a large quantity of intestinal Ag. However, our study showed that in vitro proliferation of IEL in response to OVA increased as a result of feeding ED to OVA23-3 mice (Fig. 4) . Our results are consistent with those by Sydora et al. who suggested that previous contact with Ag is not likely to be the cause of the relatively weak response of IEL. 13) CD4 ＋ IEL from ED-fed mice proliferated more markedly than IEL from CCD-fed mice, while IEL depleted of CD4 ＋ cells failed to proliferate in response to Ag (Fig. 5A) . It is unlikely that the failure of CD4 -IEL to proliferate was due to the presence of contaminating intestinal epithelial cells (IEC) which might be able to inhibit the proliferation of lymphocytes. This is supported by these results indicating that although the unfractionated IEL population as well as the CD4-depleted population might have contained a similar number of contaminating IEC, this unfractionated population was fully capable of proliferation. Although the IEC is a candidate cell population that may present antigen to IEL in vivo (discussed later), studies that have examined antigen presentation of IEC have shown that these cells inhibit T cell proliferation in vitro. 14, 15) Furthermore, in the case of murine cells, there are no appropriate intestinal epithelial cell lines that can be used in antigen presentation studies, and it is di‹cult to culture primary IEC with su‹cient purity and viability. Therefore in this study we considered that it was inadequate to use IEC as APC to examine the transition of the IEL proliferative response, and we studied its capacity to proliferate to antigenic stimulation using splenic APC.
A few other reports have shown that CD4 ＋ IEL respond to intestinal Ag, although a proliferative response has not been observed. MHC class II-restricted CD4 ＋ IEL from mice orally administered sheep red blood cells provided a Th2-like function for B cell responses. 3) In addition, it was reported that CD4 ＋ IEL in immunized mice prevented infection by Cryptosporidium muris, which induces a mucosal disease. 4) These data indicate that intestinal antigen can prime CD4 ＋ IEL speciˆcally. Our results extend these observations and indicate that Ag-speciˆc proliferation of CD4 ＋ IEL in vitro is upregulated by oral administration of Ag.
In contrast to these observations concerning CD4 ＋ IEL, the Ag-speciˆc proliferation of splenic and Peyer's patch CD4 ＋ T cells was unaŠected by OVA feeding for a relatively short period (Fig. 5B ). This is consistent with the results by another group, showing that the Ag-speciˆc proliferative activity of splenic T cells in TCR transgenic mice is not upregulated after administration of Ag, even if administration is done by immunogenic procedures. 16) From these observations, two possibilities were considered with respect to the upregulation of the proliferative activity of CD4 ＋ IEL by orally ad-ministered antigen. One is that the CD4 ＋ IEL were primed or stimulated by Ag in the intestinal epithelium, and their reactivity was upregulated. Although IEC expressing class II molecules are known to inhibit T cell proliferation in vitro, 14, 15) some studies have shown proliferation of CD4 ＋ T cells in response to antigen presentation by IEC. 17, 18) In our experiments, CD4 ＋ IEL may be primed in vivo or stimulated through interaction with OVA-derived Ag bound to I-A d molecules expressed on IEC, which are the predominant class II ＋ cells close to IEL. The upregulation of IEL proliferative capacity was found only in the case of mice administered Ag orally, but did not occur in the case of i.p. immunized mice (data not shown). These results are compatible with the view that Ag primes or stimulates IEL through the intestinal mucosa. However, we still have another possibility, that orally administered Ag primes or stimulates CD4 ＋ T cells at a site diŠerent from the intestinal epithelia and that these cells migrated into the epithelia. The Ag-speciˆc proliferative activity of systemic CD4 ＋ T cells in the spleen and Peyer's patches was not changed by orally administered Ag (Fig. 5B ). Nevertheless, their reactivity was much greater than that of the IEL, independent upon those cells from non-treated or Ag-fed Tg mice. Thus, if CD4 ＋ T cells activated by orally administered Ag outside the epithelium were recruited and inˆltrated the epithelium, the proliferative activity of these cells would be greater than that of CD4 ＋ IEL of non-treated mice. In the case of CD8 ＋ T cells, it has been reported that activated systemic T cells migrate into the epithelium. 19) We need to study the location for priming and W or stimulation of CD4 ＋ IEL. We also need to show whether CD4 ＋ IEL before Ag feeding are memory or naive cells.
The upregulation of proliferative ability suggests the possibility that CD4 ＋ IEL may proliferate in vivo in response to orally administered Ag. Further, if CD4 ＋ T cells had migrated to the epithelium, this would result in an increase of cell number. Concerning the total number of CD4 ＋ IEL, this tended to increase as a result of feeding OVA, as shown by calculations based on the total cell number and frequency (3.87±1.39×10 5 CD4 ＋ IEL in CCD-fed mice as compared to 4.87±3.00×10 5 CD4 ＋ IEL in ED-fed mice). However, this increase was slight and not statistically signiˆcant. It is possible that even if CD4 ＋ T cells expanded and W or migrated into the epithelium, some of these cells may migrate out and W or undergo apoptosis, resulting in no signiˆcant increase in the total cell number. Added to these possibilities, it is possible that number of CD8 ＋ IEL decreased. The increase in the frequency of CD4 ＋ IEL may be in part due to the decrease in the CD8 ＋ IEL population.
In this study using a TCR-transgenic model, we have demonstrated that orally administered Ag elicit-ed an increase in the proliferative response and frequency of MHC class II-restricted CD4 ＋ IEL. These results suggest that the intestinal cellular system has a mechanism by which intestinal exogenous Ags directly prime and W or stimulate CD4 ＋ IEL or localize activated CD4 ＋ T cells in the intestinal epithelium. As mentioned above, CD4 ＋ IEL in orally immunized mice have been shown to prevent infection by a parasite that induces a mucosal disease 4) and these cells provided a helper function for the Ag-speciˆc B cell response. 3) Recent studies show that CD4 ＋ T cell clones derived from the small intestinal biopsies of patients with celiac disease respond to gliadin and their derivatives, although it has been considered that these clones are derived from the lamina propria. 20, 21) These reports show that some kinds of foods may be eŠective to modify the functions of the intestinal immune system including modulation of disease and protection from infection. More studies examining the activation states and biological functions of CD4 ＋ IEL and Ag presentation are likely to aid further our understanding of the functions of IEL, and the eŠects of food components on their activities.
